TODD STRATEGY GROUP
TODD STRATEGY GROUP filed a Q3 report for GENENTECH, INC. on October 19, 2026, reporting $60,000 in lobbying income.
Lobbying for GENENTECH, INC. · Biotechnology corporation.
-
PAUL EDATTELPreviously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
-
DANIEL M TODDPreviously held: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid
-
ERIC BERGRENPreviously held: Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
-
KATHERINE FLEMING COTTONPreviously held: Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
-
NICOLAS MAGALLANESPreviously held: Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
Issues related to antimicrobial resistance and infectious disease. Issues related to public health preparedness including the SNS and supply chain. Issues related to awareness about diabetic eye diseases. Issues related to privacy and consumer information. Medical research data.
Appropriations and budget issues including: LHHS-Ed, Ag-FDA, and HHS program funding. Reconciliation and deficit reduction.
Issues related to drug pricing and coverage. Medicare and Medicaid payment issues. Implementation of the IRA. 340B Program.
Issues related to IP and patent policy reform. Issues related to FDA regulation and drug development including PDUFA and biosimilars.